Does ALEMTUZUMAB Cause Hospitalisation? 136 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Hospitalisation have been filed in association with ALEMTUZUMAB (Campath). This represents 1.0% of all adverse event reports for ALEMTUZUMAB.
136
Reports of Hospitalisation with ALEMTUZUMAB
1.0%
of all ALEMTUZUMAB reports
13
Deaths
136
Hospitalizations
How Dangerous Is Hospitalisation From ALEMTUZUMAB?
Of the 136 reports, 13 (9.6%) resulted in death, 136 (100.0%) required hospitalization, and 7 (5.1%) were considered life-threatening.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 136 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which ALEMTUZUMAB Alternatives Have Lower Hospitalisation Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET